These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 2440704)

  • 1. Effects of the alpha 2-antagonist idazoxan on monoaminergic parameters measured in the cerebrospinal fluid of rabbits.
    Dillen L; Claeys M; De Potter WP
    Eur J Pharmacol; 1987 May; 137(1):33-40. PubMed ID: 2440704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of parameters for central neuronal activity in cerebrospinal fluid of rabbits following yohimbine.
    Dillen L; Claeys M; De Potter WP
    Biochem Pharmacol; 1986 Nov; 35(22):3977-82. PubMed ID: 2430573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of yohimbine and idazoxan on monoamine metabolites in rat cerebrospinal fluid.
    Scheinin H; Virtanen R
    Life Sci; 1986 Oct; 39(16):1439-46. PubMed ID: 2430157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selected ion monitoring analysis of monoamine metabolites in cerebrospinal fluid. Application to the study of in vivo effects of alpha 2-antagonists.
    Dillen L; Duchateau A; De Potter WP; Claeys M
    Biomed Environ Mass Spectrom; 1987 Nov; 14(11):675-82. PubMed ID: 2892549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concentration gradients of monoamine metabolites in human cerebrospinal fluid.
    Sjöström R; Ekstedt J; Anggård E
    J Neurol Neurosurg Psychiatry; 1975 Jul; 38(7):666-8. PubMed ID: 1159438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced noradrenergic neuronal activity increases homovanillic acid levels in cerebrospinal fluid.
    Scheinin H
    J Neurochem; 1986 Sep; 47(3):665-7. PubMed ID: 3016178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Central administration of yohimbine increases free 3-methoxy-4-hydroxyphenylglycol in the cerebrospinal fluid of the rat.
    Mignot E; Laude D; Elghozi JL; Le Quan-Bui KH; Meyer P
    Eur J Pharmacol; 1982 Sep; 83(1-2):135-8. PubMed ID: 6182009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age effect on dopamine and serotonin metabolite levels in cerebrospinal fluid.
    Seifert WE; Foxx JL; Butler IJ
    Ann Neurol; 1980 Jul; 8(1):38-42. PubMed ID: 6157351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoamine metabolites in the CSF of epileptic patients.
    Laxer KD; Sourkes TL; Fang TY; Young SN; Gauthier SG; Missala K
    Neurology; 1979 Aug; 29(8):1157-61. PubMed ID: 37460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoamine metabolites in human cerebrospinal fluid: indicators of neuronal activity?
    Scheinin M
    Med Biol; 1985; 63(1):1-17. PubMed ID: 2582215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monoamine metabolite concentrations in lumbar cerebrospinal fluid of patients with histologically verified Alzheimer's dementia.
    Palmer AM; Sims NR; Bowen DM; Neary D; Palo J; Wikstrom J; Davison AN
    J Neurol Neurosurg Psychiatry; 1984 May; 47(5):481-4. PubMed ID: 6204017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spinal reflexes and the concentrations of 5-HIAA, MHPG, and HVA in lumbar cereborspinal fluid after spinal lesions in man.
    Ashby P; Verrier M; Warsh JJ; Price KS
    J Neurol Neurosurg Psychiatry; 1976 Dec; 39(12):1191-200. PubMed ID: 1011029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose-response relationship for oral idazoxan effects in healthy human subjects: comparison with oral yohimbine.
    Krystal JH; McDougle CJ; Woods SW; Price LH; Heninger GR; Charney DS
    Psychopharmacology (Berl); 1992; 108(3):313-9. PubMed ID: 1355923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amine metabolites in ventricular cerebrospinal fluid in coma.
    Yates CM; Tsementzis SA; Wilson H
    J Neurol Neurosurg Psychiatry; 1979 Oct; 42(10):887-91. PubMed ID: 512664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selectivity and potency of 2-alkyl analogues of the alpha 2-adrenoceptor antagonist idazoxan (RX 781094) in peripheral systems.
    Doxey JC; Roach AG; Strachan DA; Virdee NK
    Br J Pharmacol; 1984 Nov; 83(3):713-22. PubMed ID: 6150740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 2-Alkyl analogue of idazoxan (RX 781094) with enhanced antagonist potency and selectivity at central alpha 2-adrenoceptors in the rat.
    Gadie B; Lane AC; McCarthy PS; Tulloch IF; Walter DS
    Br J Pharmacol; 1984 Nov; 83(3):707-12. PubMed ID: 6150739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CSF monoamine metabolites in mania.
    Swann AC; Secunda S; Davis JM; Robins E; Hanin I; Koslow SH; Maas JW
    Am J Psychiatry; 1983 Apr; 140(4):396-400. PubMed ID: 6188381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biogenic amine metabolites in human CSF after hypoxia due to cardiac arrest.
    Odink J; Kärkelä J; Thissen JT; Marnela KM
    Acta Neurol Scand; 1989 Jul; 80(1):6-11. PubMed ID: 2476907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebrospinal fluid monoamine metabolites during alcohol withdrawal syndrome and recovered state.
    Fujimoto A; Nagao T; Ebara T; Sato M; Otsuki S
    Biol Psychiatry; 1983 Oct; 18(10):1141-52. PubMed ID: 6197099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monoamine metabolite levels in cerebrospinal fluid and brain atrophy in lobotomized schizophrenic patients.
    Rimón R; Roos BE; Kampman R; Hyyppä S; Ranta P; Myllylä V
    Ann Clin Res; 1979 Feb; 11(1):25-9. PubMed ID: 453776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.